| Product Code: ETC12942826 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea mRNA Vaccines and Therapeutics Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea mRNA Vaccines and Therapeutics Market - Industry Life Cycle |
3.4 South Korea mRNA Vaccines and Therapeutics Market - Porter's Five Forces |
3.5 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Therapeutic Type, 2021 & 2031F |
3.7 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.9 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 South Korea mRNA Vaccines and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government support and funding for mRNA vaccine development in South Korea |
4.2.2 Rising prevalence of infectious diseases, driving the demand for innovative vaccine solutions |
4.2.3 Growing investments in research and development activities by pharmaceutical companies in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for mRNA vaccines in South Korea |
4.3.2 High initial investment costs and production complexities associated with mRNA therapeutics |
5 South Korea mRNA Vaccines and Therapeutics Market Trends |
6 South Korea mRNA Vaccines and Therapeutics Market, By Types |
6.1 South Korea mRNA Vaccines and Therapeutics Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Vaccine Type, 2021 - 2031F |
6.1.3 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By COVID-19 Vaccine, 2021 - 2031F |
6.1.4 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Influenza Vaccine, 2021 - 2031F |
6.1.5 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Rabies Vaccine, 2021 - 2031F |
6.1.6 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Zika Virus Vaccine, 2021 - 2031F |
6.1.7 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By CMV Vaccine, 2021 - 2031F |
6.2 South Korea mRNA Vaccines and Therapeutics Market, By Therapeutic Type |
6.2.1 Overview and Analysis |
6.2.2 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031F |
6.2.3 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Personalized Cancer Vaccine, 2021 - 2031F |
6.2.4 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Protein Replacement Therapy, 2021 - 2031F |
6.2.5 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Autoimmune Disease Treatment, 2021 - 2031F |
6.2.6 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By mRNA-Based Drug Delivery, 2021 - 2031F |
6.3 South Korea mRNA Vaccines and Therapeutics Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3.3 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.4 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Genetic Disorders, 2021 - 2031F |
6.3.5 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Neurological Disorders, 2021 - 2031F |
6.3.6 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.4 South Korea mRNA Vaccines and Therapeutics Market, By Delivery Method |
6.4.1 Overview and Analysis |
6.4.2 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Intramuscular Injection, 2021 - 2031F |
6.4.3 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Subcutaneous Injection, 2021 - 2031F |
6.4.4 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Intradermal Injection, 2021 - 2031F |
6.4.5 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Intravenous Infusion, 2021 - 2031F |
6.4.6 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Oral Delivery, 2021 - 2031F |
6.5 South Korea mRNA Vaccines and Therapeutics Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5.3 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.5.4 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5.5 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.5.6 South Korea mRNA Vaccines and Therapeutics Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
7 South Korea mRNA Vaccines and Therapeutics Market Import-Export Trade Statistics |
7.1 South Korea mRNA Vaccines and Therapeutics Market Export to Major Countries |
7.2 South Korea mRNA Vaccines and Therapeutics Market Imports from Major Countries |
8 South Korea mRNA Vaccines and Therapeutics Market Key Performance Indicators |
8.1 Research and development expenditure in mRNA vaccine and therapeutics development |
8.2 Number of clinical trials conducted for mRNA vaccines in South Korea |
8.3 Adoption rate of mRNA vaccines in the healthcare system |
8.4 Number of partnerships and collaborations between local and international pharmaceutical companies in mRNA vaccine development |
9 South Korea mRNA Vaccines and Therapeutics Market - Opportunity Assessment |
9.1 South Korea mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 South Korea mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Therapeutic Type, 2021 & 2031F |
9.3 South Korea mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 South Korea mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
9.5 South Korea mRNA Vaccines and Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 South Korea mRNA Vaccines and Therapeutics Market - Competitive Landscape |
10.1 South Korea mRNA Vaccines and Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 South Korea mRNA Vaccines and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here